Brief: JR Holding Signs Investement Agreement With Medcamp And Genxone Regarding Financing Research On SARS–CoV–2

JRH ASI SA

06/04/2020 09:06

April 6 (Reuters) - JR Holding Alternatywna Spolka
Inwestycyjna SA  JRH.WA :
    * SIGNS INVESTEMENT UNDERSTANDING WITH MEDCAMP AND GENXONE
REGARDING FINANCING RESEARCH ON SARS-COV-2
    * GENXONE HAS SCIENTIFIC AND RESEARCH POTENTIAL TO DO
RESEARCH IN
SARS-COV-2, RESULTS OF RESEARCH CAN CONTRIBUTE TO ACCELERATE
WORK ON VACCINE AND DRUG FOR COVID - 19
    * UNDER AGREEMENT, COMPANIES INTEND TO COOPERATE ON
FINANCING
RESEARCH ON SARS-COV-2
    * COMMITS TO ACQUIRE GENXONE SHARES FROM NEW ISSUE FOR AT
LEAST
0.5 MILLION ZLOTYS
    * FUNDS OBTAINED BY GENXONE WILL BE USED FOR ITS CURRENT
ACTIVITY,
INCLUDING RESEARCH ON CORONAVIRUS

Source text for Eikon:  ID:nEM8fTrcGa 
Further company coverage:  JRH.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))